Download drug analysis - WordPress.com

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Biosimilar wikipedia , lookup

Plateau principle wikipedia , lookup

Electronic prescribing wikipedia , lookup

Polysubstance dependence wikipedia , lookup

Pharmaceutical marketing wikipedia , lookup

Specialty drugs in the United States wikipedia , lookup

Compounding wikipedia , lookup

Stimulant wikipedia , lookup

Orphan drug wikipedia , lookup

Bad Pharma wikipedia , lookup

Drug design wikipedia , lookup

Drug discovery wikipedia , lookup

Neuropharmacology wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Pharmacognosy wikipedia , lookup

Pharmaceutical industry wikipedia , lookup

Psychopharmacology wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Medication wikipedia , lookup

Prescription costs wikipedia , lookup

Drug interaction wikipedia , lookup

Transcript
DRUG ANALYSIS
G M Kellerman
Hunter Area Pathology Service
REASONS FOR ANALYSIS
ILLEGAL DRUGS
•
•
•
•
•
•
•
•
In many cases where there is a request for identification or measurement
the question is of illicit drug use
This comes from sporting events or illegal street drugs
In either case there is big money involved somewhere, and in many
countries penalties are very severe for street drugs, up to and including the
death penalty
So it may be enough to identify that a drug is present, no matter how little,
or there may be an upper limit permitted (e.g. caffeine in athletes)
On occasions there is an attempt to monitor abstinence from a long-lasting
drug, so decreasing levels are sought (e.g. cannabinoids)
Tests may therefore be qualitative or quantitative
In view of the legal requirements, it is essential to document the “chain of
custody” rigorously
There are some specialist veterinary laboratories for race horses etc
REASONS FOR ANALYSIS
PRESCRIPTION DRUGS
• Requests for analysis of prescription drugs are made to investigate:
• Compliance by the patient – is the level as expected for dose?
• Adequacy of dose – is plasma level within an established
therapeutic range, high or low (e.g. thyroxine)?
• Is there evidence of unusual drug metabolism, with excessively high
or low plasma levels (e.g. INH, azathioprine)?
• Is the excretory capacity as expected, or low (e.g. aminoglycosides,
digoxin, where toxicity can develop)?
• Do we need to assay a trough level, before the next dose, or a peak
level, or a whole time/concentration graph to measure AUC (e.g.
immunosuppressives such as cyclosporine)?
• Overdoses, where knowledge of nature or level of drug has
therapeutic implications (e.g. paracetamol)
ILLICIT DRUGS - 1
• There are many ways to identify and quantitate such drugs, either by
direct measurement, measurement of metabolites or measurement
of physiological effects (e.g. high Hb with EPO)
• Simple slide based immunological tests which contain a built-in
positive control are used for many purposes (home pregnancy kits,
LH spike detectors etc) and they have been adapted for use in
emergency departments for many of the so-called “recreational”
drugs such as opiates, cannabis, amphetamines, cocaine.
However, they have limited range (e.g. opiates detect the morphine
rings and do not react to pethidine {demerol} or methadone) and
there is no single antibody good enough to find all the possible
benzodiazepines at relevant concentrations. So “date rape”
investigations are difficult
• Most of these slides are used to guide therapy in hospital and the
chain of custody requirements are seldom if ever met
ILLICIT DRUGS - 2
• Quantitative methods involve separation – usually HPLC – and
analysis by suitable detectors. Frequently extraction steps and/or
chemical or enzymatic hydrolysis are needed
• Modern methodology is favouring the use of mass spectrometry for
the final identification and quantitation, usually with internal standard
deuterated compounds to control for incompleteness of the steps in
the preliminary workup. This technology has much broader range of
identification and more reliable quantitation, but it is expensive for
normal requirements. When the big money or severe penalties are
considered, it is cheap!
• Sports drugs are so important to that sector of the community that
they are the province of specialist laboratories and normal clinical
chemists never see them. We do receive quite a number of
samples from surveys of employees for illegal drug use. Many
users become experts at eluding tests – watering urine etc
PRESCRIPTION DRUGS - 1
• To interpret such results, it is necessary to have a firm basic
knowledge of the pharmacokinetics of the drug (the rate of
absorption, excretion or metabolism), the pharmacodynamics of the
drug ( dose-response curves, toxicities) and the extensive set of
drug interactions that seems to grow every year
• Hence the collaboration of the clinical chemist with the
pharmacologist or at least the hospital pharmacist is essential, and
computerised data bases are being developed and widely used
• In our laboratory we assay only those drugs for which there is a
clear relationship between level and either activity or toxicity,
especially if the pharmacokinetics differ widely among the population
either for genetic or disease reasons. For the genetic problems we
are tending to assay the affected enzymes or even the genes for
preference to dose/effect measurements
PRESCRIPTION DRUGS - 2
• There is no substitute for knowledge of the health of the organs
which do the metabolism or excretion – so liver disease and
especially kidney disease (even mild) is of great importance.
• Some of the drugs we measure are:
• Digoxin – excreted by kidney in proportion to GFR and plasma
creatinine is not a really adequate criterion – eGFR is better. The K
level at the same time is needed due to interaction at the Na-K
ATPase level. As we recognise toxic effects even at low levels,
especially in women, this assay becomes more critical
• Aminoglycosides – excreted by kidney and hence levels are higher
as GFR decreases. This is even more important as it is believed
that a period without the drug in the day is beneficial to its action, so
we need to ensure that the level drops adequately. Further, the drug
is nephro- and oto-toxic and levels must not be too high for long
PRESCRIPTION DRUGS - 3
• Antiepileptics, especially phenytoin because of its saturation kinetics
of metabolism. This means that when the mechanism is saturated,
the plasma level rises rapidly for small increments in dose
• Carbamazepine and valproate are usually monitored, especially if in
combination, as they and phenytoin and phenobarbitone all compete
for albumin binding sites and allowances have to be made when
more than one is administered. N.B. free fatty acids in starvation
and a host of other drugs are also protein bound and compete
• Lithium is a very difficult drug to control and levels are often high or
low. Patients of this type are often variably compliant and also
sometimes suicidal, and there is an interaction with the Na content
of the diet to make it harder. Monitoring is mandatory
• We often get requests for atypical antiepileptics and antidepressives
Most of these do not have a clear dose/response relationship, but
are tested for compliance. Clozapine is probably worth while
PRESCRIPTION DRUGS - 4
• One could write a whole book on the interactions with warfarin –
suffice it to say that we give advice to the patient on diet and VITK
intake, and monitor with INR
• Increasing knowledge of the specific cytochrome P450 enzymes
responsible for drug metabolism and the characteristics of their
induction/repression/competition is opening a new field of
understanding for people who regularly prescribe drugs, but it
means that the occasional prescriber will need to consult experts
• There are a number of other drugs that we occasionally measure –
theophylline, lidocaine, salicylate, flecainide, perhexiline,
amiodarone, itraconazole, some HIV drugs, but such requests are
becoming less frequent as the popularity of drugs changes
PARACETAMOL
(ACETAMINOPHEN)
• This mild analgesic causes more trouble that probably any other
single drug because it is still a favourite means of attempted suicide
particularly in young women
• Most appear fairly soon after administration and their plasma level
can be compared to the published nomogram to establish the risk of
severe toxicity. They can then be given N-acetylcysteamine and
suffer no ill effects – but we had one who used to come in 3 times a
week for months!
• Occasionally patients delay presentation until they begin to feel ill on
day 2 or 3, and then they have little or no residual drug but the liver
function tests show derangement – some transaminases are in the
thousands and bilirubin is raised. It is usually possible to obtain the
history of overdose. So far as I know we have had only 2 deaths
over many years
POISONING
• The surfeit of toxic chemicals available for suicidal attempts,
accidental intake or low level intake in food, water etc makes this a
difficult field.
• We send most of the requests to the government office called
“Workcover” which maintains methods for many such chemicals
• We can (and do) analyses for traces of toxic metals such as As, Cd,
Zn, Cu, Mn, Hg etc by mass spectroscopy
• The most urgent tests we have are for cholinesterase in suspected
(or known) organophosphate or carbamylphosphate poisoning,
including monitoring of crop sprayers using these chemicals. The
screen is for “pseudocholinesterase” (= butyrylcholinesterase) and if
in doubt the true “acetylcholinesterase” can be measured in red cells
as an index of severe toxicity. Mixing tests with normal plasma can
detect residual toxin
• Remember, people will drink “anything that pours” even 90% phenol